Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Werewolf Therapeutics, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 61
- +21 vs. Q4 2023
- Shares held
- 32.3M
- +4.58M (+16.6%) vs. Q4 2023
- Total value
- $209.0M
- +$102.2M (+95.7%) vs. Q4 2023
- New holders
- 25
- 15 more added
- Sold out
- 4
- 12 more reduced
1 institution that held it in Q4 2023 haven't filed for Q1 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HOWL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $3.91M |
| Q1 2026 | 48 | $11.7M |
| Q4 2025 | 51 | $9.34M |
| Q3 2025 | 62 | $41.6M |
| Q2 2025 | 65 | $24.3M |
| Q1 2025 | 70 | $26.7M |
| Q4 2024 | 73 | $41.7M |
| Q3 2024 | 69 | $68.3M |
| Q2 2024 | 71 | $79.2M |
| Q1 2024 | 61 | $209.0M |
| Q4 2023 | 41 | $106.8M |
| Q3 2023 | 35 | $51.1M |
| Q2 2023 | 36 | $73.3M |
| Q1 2023 | 38 | $62.5M |
| Q4 2022 | 39 | $42.8M |
| Q3 2022 | 44 | $94.5M |
| Q2 2022 | 46 | $78.0M |
| Q1 2022 | 49 | $83.5M |
| Q4 2021 | 51 | $228.3M |
| Q3 2021 | 42 | $326.2M |
| Q2 2021 | 45 | $344.3M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Werewolf Therapeutics, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 42 | $0 | 0.00% | +42 | New |
| Macquarie Group Ltd | 940 | $6 | 0.00% | +940 | New |
| UBS Group AG | 37 | $240 | 0.00% | −963−96.3% | Reduced |
| Simplex Trading, LLC | 202 | $1.00K | 0.00% | −5,496−96.5% | Reduced |
| Wells Fargo & Company | 194 | $1.26K | 0.00% | +40+26.0% | Added |
| Barclays PLC | 1,878 | $12.2K | 0.00% | +1,878 | New |
| Citadel Advisors LLC | 3,073 | $19.9K | 0.00% | −18,449−85.7% | Reduced |
| Financial Perspectives, Inc | 6,750 | $43.7K | 0.02% | 00.0% | Unchanged |
| Camden Capital, LLC | 10,000 | $64.8K | 0.01% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 10,537 | $68.3K | 0.00% | +10,537 | New |
| Omers Administration Corp | 10,800 | $70.0K | 0.00% | +10,800 | New |
| HBK Sorce Advisory LLC | 13,227 | $85.7K | 0.00% | −13,227−50.0% | Reduced |
| Y-Intercept (Hong Kong) Ltd | 14,154 | $91.7K | 0.01% | +14,154 | New |
| Brevan Howard Capital Management LP | 18,910 | $122.5K | 0.01% | +18,910 | New |
| Morgan Stanley | 20,579 | $133.4K | 0.00% | +19,979+3,329.8% | Added |
| Balyasny Asset Management LLC | 23,048 | $149.4K | 0.00% | +23,048 | New |
| Point72 Asia (Singapore) Pte. Ltd. | 23,264 | $150.8K | 0.04% | +23,264 | New |
| Raymond James Financial Services Advisors, Inc. | 23,659 | $153.3K | 0.00% | +23,659 | New |
| Squarepoint Ops LLC | 24,594 | $159.4K | 0.00% | +24,594 | New |
| American Century Companies Inc | 24,978 | $161.9K | 0.00% | +24,978 | New |
| ExodusPoint Capital Management, LP | 25,240 | $164.0K | 0.00% | +25,240 | New |
| Marshall Wace, LLP | 26,284 | $170.3K | 0.00% | +26,284 | New |
| Denali Advisors LLC | 26,600 | $172.4K | 0.05% | +26,600 | New |
| Royce & Associates LP | 37,321 | $241.8K | 0.00% | +37,321 | New |
| HRT Financial LP | 37,628 | $243.0K | 0.00% | +37,628 | New |
| Cubist Systematic Strategies, LLC | 40,649 | $263.4K | 0.00% | +40,649 | New |
| Northern Trust Corp | 48,502 | $314.3K | 0.00% | −1,146−2.3% | Reduced |
| Edgewood Management LLC | 50,000 | $324.0K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 71,168 | $461.2K | 0.00% | −12,300−14.7% | Reduced |
| JPMorgan Chase & Co | 71,184 | $461.3K | 0.00% | +71,101+85,663.9% | Added |
| Citigroup Inc | 71,556 | $463.7K | 0.00% | +71,556 | New |
| Man Group plc | 79,639 | $516.1K | 0.00% | +79,639 | New |
| Renaissance Technologies LLC | 84,200 | $546.0K | 0.00% | −23,306−21.7% | Reduced |
| Bridgeway Capital Management, LLC | 85,086 | $551.4K | 0.01% | 00.0% | Unchanged |
| Dimensional Fund Advisors LP | 111,625 | $723.3K | 0.00% | +48,702+77.4% | Added |
| Qube Research & Technologies Ltd | 117,013 | $758.2K | 0.00% | +114,629+4,808.3% | Added |
| Jane Street Group, LLC | 157,226 | $1.02M | 0.00% | +142,739+985.3% | Added |
| BlackRock Inc. | 164,792 | $1.07M | 0.00% | +92,564+128.2% | Added |
| Acadian Asset Management LLC | 172,883 | $1.12M | 0.00% | +94,212+119.8% | Added |
| Goldman Sachs Group Inc | 172,794 | $1.12M | 0.00% | +172,794 | New |
| Susquehanna International Group, LLP | 175,798 | $1.14M | 0.00% | +161,021+1,089.7% | Added |
| Two Sigma Investments, LP | 185,059 | $1.20M | 0.00% | +38,323+26.1% | Added |
| Laurion Capital Management LP | 201,236 | $1.30M | 0.04% | +122,023+154.0% | Added |
| Alyeska Investment Group, L.P. | 235,705 | $1.53M | 0.01% | −200,000−45.9% | Reduced |
| Two Sigma Advisers, LP | 247,600 | $1.60M | 0.00% | +70,300+39.7% | Added |
| Geode Capital Management, LLC | 259,680 | $1.68M | 0.00% | +65,372+33.6% | Added |
| Millennium Management LLC | 565,417 | $3.66M | 0.00% | +121,058+27.2% | Added |
| Verition Fund Management LLC | 571,466 | $3.70M | 0.04% | +571,466 | New |
| DC Funds, LP | 589,102 | $3.82M | 36.89% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 626,810 | $4.06M | 0.66% | 00.0% | Unchanged |
| Eagle Health Investments LP | 700,000 | $4.54M | 0.86% | +700,000 | New |
| Monashee Investment Management LLC | 890,000 | $5.77M | 0.68% | +890,000 | New |
| Vanguard Group Inc | 1,107,347 | $7.18M | 0.00% | +233,909+26.8% | Added |
| Rubric Capital Management LP | 1,621,034 | $10.5M | 0.31% | −314,323−16.2% | Reduced |
| Janus Henderson Group PLC | 1,688,054 | $10.9M | 0.01% | +1,688,054 | New |
| Bank of America Corp | 1,881,113 | $12.2M | 0.00% | −214,968−10.3% | Reduced |
| MPM Oncology Impact Management LP | 2,388,011 | $15.5M | 2.49% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 3,000,594 | $19.4M | 0.04% | −33,661−1.1% | Reduced |
| PFM Health Sciences, LP | 3,006,734 | $19.5M | 0.97% | −461,443−13.3% | Reduced |
| MPM Asset Management LLC | 4,284,172 | $27.8M | 11.32% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 6,144,881 | $39.8M | 0.51% | 00.0% | Unchanged |
| Lighthouse Investment Partners, LLC | 0 | $0 | 0.00% | −22,472−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −20,383−100.0% | Sold out |
| Prudential Financial Inc | 0 | $0 | 0.00% | −15,400−100.0% | Sold out |
| Group One Trading, L.P. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Baystate Wealth Management LLC | – | – | – | – | Not filed |